CAMBRIDGE, MA, USA I July 10, 2017 I Scholar Rock, a biotechnology company focused on discovering and developing drugs that selectively target growth factors in the disease microenvironment, today announced the presentation of data from its SRK-015 antibody program, in collaboration…